Regeneron Pharmaceuticals Inc
REGN
NASDAQ
Biotechnology
$803.48
USD
-2.49 (-0.31%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $82.16B
Volume 424.5K
Price Target
$750.00 – $875.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $875.00 and a min estimate of $750.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$812.50
+$1.8 vs prior
Implied Upside
+1.1%
+0.2% vs prior
Analyst Covering
2
-12 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
13%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Carter Gould | Cantor Fitzgerald | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
John Newman | Canaccord Genuity | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Andrew Berens | Leerink Partners | Hold | Downgraded | 3 months ago | Plus | Plus | Plus |
Geoff Meacham | Citigroup | Hold | Downgraded | 3 months ago | Plus | Plus | Plus |
Brian Abrahams | RBC Capital | Hold | Maintained | 3 months ago | Plus | Plus | Plus |
Frequently Asked Questions
